biospecimen__admin__batch_number	304.65.0
biospecimen__admin__bcr	Nationwide Children's Hospital
biospecimen__admin__day_of_dcc_upload	6
biospecimen__admin__dbgap_registration_code	000178
biospecimen__admin__disease_code	ACC
biospecimen__admin__file_uuid	5E276791-3FFE-42A2-80A2-13A75FE16533
biospecimen__admin__month_of_dcc_upload	11
biospecimen__admin__program	TCGA
biospecimen__admin__year_of_dcc_upload	2018
biospecimen__bio__bcr_analyte_barcode	TCGA-OR-A5LO-01A-11R
biospecimen__bio__bcr_portion_barcode	TCGA-OR-A5LO-01A-11
biospecimen__bio__bcr_sample_barcode	TCGA-OR-A5LO-01A
biospecimen__bio__biospecimen_barcode_bottom	0145632270
biospecimen__bio__day_of_creation	06
biospecimen__bio__day_of_shipment	08
biospecimen__bio__days_to_index	0
biospecimen__bio__gel_image_file	https://sharedoc.nchri.org/tcga-bcr/default.aspx
biospecimen__bio__is_derived_from_ffpe	NO
biospecimen__bio__month_of_creation	02
biospecimen__bio__month_of_shipment	05
biospecimen__bio__pathology_report_file_name	TCGA-OR-A5LO.45C2478C-53EF-4422-A9EF-33C40A3AA275.pdf
biospecimen__bio__plate_column	7
biospecimen__bio__plate_id	A29S
biospecimen__bio__plate_row	B
biospecimen__bio__portion_sequence	1
biospecimen__bio__quantity	2.21
biospecimen__bio__subportion_sequence	1
biospecimen__bio__vial_number	A
biospecimen__bio__volume	13.00
biospecimen__bio__year_of_creation	2013
biospecimen__bio__year_of_shipment	2013
biospecimen__shared__bcr_patient_barcode	TCGA-OR-A5LO
biospecimen__shared__patient_id	A5LO
clinical__acc_shared__atypical_mitotic_figures	Atypical Mitotic Figures Present
clinical__acc_shared__cytoplasm_presence_less_than_equal_25_percent	Cytoplasm presence <= 25% Present
clinical__acc_shared__diffuse_architecture	Diffuse Architecture Present
clinical__acc_shared__excess_adrenal_hormone_diagnosis_method_type	Both Clinical and Biochemical Assessments
clinical__acc_shared__excess_adrenal_hormone_history_type	Estrogen
clinical__acc_shared__invasion_of_tumor_capsule	Invasion of Tumor Capsule Present
clinical__acc_shared__mitoses_count	12
clinical__acc_shared__mitotane_therapy	YES
clinical__acc_shared__mitotane_therapy_adjuvant_setting	YES
clinical__acc_shared__mitotic_rate	Mitotic Rate > 5/50 HPF Present
clinical__acc_shared__necrosis	Necrosis Present
clinical__acc_shared__nuclear_grade_iii_iv	Nuclear Grade III or IV Present
clinical__acc_shared__sinusoid_invasion	Sinusoid Invasion Absent
clinical__acc_shared__therapeutic_mitotane_levels_achieved	YES
clinical__acc_shared__therapeutic_mitotane_lvl_recurrence	YES
clinical__acc_shared__weiss_score	7
clinical__acc_shared__weiss_venous_invasion	Venous Invasion Absent
clinical__admin__batch_number	304.64.0
clinical__admin__day_of_dcc_upload	22
clinical__admin__file_uuid	306C1664-610A-498A-8251-C1B67E3D46C0
clinical__admin__month_of_dcc_upload	12
clinical__admin__withdrawn	false
clinical__admin__year_of_dcc_upload	2016
clinical__clin_shared__age_at_initial_pathologic_diagnosis	61
clinical__clin_shared__bcr_followup_barcode	TCGA-OR-A5LO-F59577
clinical__clin_shared__bcr_followup_uuid	00C7E858-F45B-462F-9926-ABEAC3B21FA8
clinical__clin_shared__ct_scan	YES
clinical__clin_shared__ct_scan_findings	Normal
clinical__clin_shared__day_of_form_completion	15
clinical__clin_shared__days_to_initial_pathologic_diagnosis	0
clinical__clin_shared__informed_consent_verified	YES
clinical__clin_shared__laterality	Right
clinical__clin_shared__lost_follow_up	NO
clinical__clin_shared__lymph_node_examined_count	19
clinical__clin_shared__month_of_form_completion	3
clinical__clin_shared__number_of_lymphnodes_positive_by_he	0
clinical__clin_shared__person_neoplasm_cancer_status	WITH TUMOR
clinical__clin_shared__post_surgical_procedure_assessment_thyroid_gland_carcinoma_status	No imaging evidence of disease
clinical__clin_shared__postoperative_rx_tx	YES
clinical__clin_shared__primary_lymph_node_presentation_assessment	YES
clinical__clin_shared__primary_therapy_outcome_success	Complete Remission/Response
clinical__clin_shared__radiation_therapy	NO
clinical__clin_shared__residual_tumor	R0
clinical__clin_shared__tissue_prospective_collection_indicator	NO
clinical__clin_shared__tissue_retrospective_collection_indicator	YES
clinical__clin_shared__tumor_tissue_site	Adrenal
clinical__clin_shared__year_of_form_completion	2014
clinical__clin_shared__year_of_initial_pathologic_diagnosis	2008
clinical__nte__additional_pharmaceutical_therapy	YES
clinical__nte__additional_radiation_therapy	YES
clinical__nte__days_to_new_tumor_event_additional_surgery_procedure	1309
clinical__nte__days_to_new_tumor_event_after_initial_treatment	153
clinical__nte__histologic_disease_progression_present_indicator	YES
clinical__nte__new_neoplasm_confirmed_diagnosis_method_name	Imaging
clinical__nte__new_neoplasm_event_occurrence_anatomic_site	Lymph Node(s)
clinical__nte__new_neoplasm_event_type	Distant Metastasis
clinical__nte__new_tumor_event_additional_surgery_procedure	YES
clinical__nte__new_tumor_event_after_initial_treatment	YES
clinical__shared__germline_testing_performed	NO
clinical__shared__histological_type	Adrenocortical carcinoma- Usual Type
clinical__shared__history_of_neoadjuvant_treatment	No
clinical__shared__other_dx	No
clinical__shared_stage__clinical_m	M0
clinical__shared_stage__pathologic_n	N0
clinical__shared_stage__pathologic_t	T2
gcm_curated__age	22370
gcm_curated__alt_biosample_source_id	TCGA-OR-A5LO-01A
gcm_curated__alt_donor_source_id	TCGA-OR-A5LO
gcm_curated__alt_item_source_id	TCGA-OR-A5LO-01A-11R-A29S-07
gcm_curated__assembly	GRCh38
gcm_curated__biological_replicate_count	1
gcm_curated__biological_replicate_number	1
gcm_curated__biosample_source_id	55ee2b0e-feff-4f93-982a-5b64820b7a34
gcm_curated__biosample_type	tissue
gcm_curated__case_source_id	1d5602a7-72e7-4dc6-b2db-2f778fcbf475
gcm_curated__checksum	b2642dd8b192f5d13da015bce9d19f70
gcm_curated__data_type	Gene Expression Quantification
gcm_curated__dataset_name	GRCh38_TCGA_gene_expression_2019_10
gcm_curated__date	2019-09-12T10:50:17.000000+02:00
gcm_curated__disease	Adrenocortical Carcinoma
gcm_curated__donor_source_id	1d5602a7-72e7-4dc6-b2db-2f778fcbf475
gcm_curated__ethnicity	not reported
gcm_curated__external_reference	https://portal.gdc.cancer.gov/cases/1d5602a7-72e7-4dc6-b2db-2f778fcbf475
gcm_curated__feature	gene expression
gcm_curated__file_format	BED
gcm_curated__file_name	a70e4d3e-993e-4ab7-95b9-1c52f452ef63-geq.bed
gcm_curated__gender	female
gcm_curated__is_annotation	false
gcm_curated__is_healthy	false
gcm_curated__item_source_id	a70e4d3e-993e-4ab7-95b9-1c52f452ef63-geq
gcm_curated__local_url	http://www.gmql.eu/gmql-rest/datasets/public.GRCh38_TCGA_gene_expression_2019_10/a70e4d3e-993e-4ab7-95b9-1c52f452ef63-geq/region
gcm_curated__pipeline	HTSeq - Counts, HTSeq - FPKM, HTSeq - FPKM-UQ
gcm_curated__project_name	TCGA-ACC
gcm_curated__replicate_source_id	55ee2b0e-feff-4f93-982a-5b64820b7a34
gcm_curated__size	5102284
gcm_curated__source	TCGA
gcm_curated__source_page	https://portal.gdc.cancer.gov/files/98e70b10-be6a-43d9-8c8e-0c7354e4d625,https://portal.gdc.cancer.gov/files/c1d41401-9e14-427a-9b03-83caea8b9669,https://portal.gdc.cancer.gov/files/b13850ad-8815-4901-b306-a8e991c96844
gcm_curated__source_site	University of Michigan
gcm_curated__source_url	ftp://geco.deib.polimi.it/opengdc/bed/tcga/tcga-acc/gene_expression_quantification/a70e4d3e-993e-4ab7-95b9-1c52f452ef63-geq.bed
gcm_curated__species	Homo sapiens
gcm_curated__technical_replicate_count	1
gcm_curated__technical_replicate_number	1_1
gcm_curated__technique	RNA-Seq
gcm_curated__tissue	Adrenal gland
gdc__access	open
gdc__acl	open
gdc__aliquots__aliquot_id	a70e4d3e-993e-4ab7-95b9-1c52f452ef63
gdc__aliquots__concentration	0.17
gdc__aliquots__source_center	23
gdc__aliquots__submitter_id	TCGA-OR-A5LO-01A-11R-A29S-07
gdc__aliquots__updated_datetime	2018-11-28T09:16:30.888868-06:00
gdc__analysis__analysis_id	8af43270-fa00-485f-84d8-462ea05827cd,6eddbd57-4aca-4995-a3e3-d3523c88afde,fd5766f0-0a5b-4abe-9faa-1d050d58a034
gdc__analysis__workflow_link	https://github.com/NCI-GDC/htseq-cwl
gdc__analysis__workflow_type	HTSeq - FPKM-UQ,HTSeq - Counts,HTSeq - FPKM
gdc__analysis__workflow_version	v1
gdc__analytes__a260_a280_ratio	1.89
gdc__analytes__analyte_id	fb6ec8f6-53df-4477-9412-29c5120c444e
gdc__analytes__analyte_type	RNA
gdc__analytes__analyte_type_id	R
gdc__analytes__concentration	0.17
gdc__analytes__spectrophotometer_method	UV Spec
gdc__case_id	1d5602a7-72e7-4dc6-b2db-2f778fcbf475
gdc__center__center_id	ee7a85b3-8177-5d60-a10c-51180eb9009c
gdc__center__center_type	CGCC
gdc__center__code	07
gdc__center__name	University of North Carolina
gdc__center__namespace	unc.edu
gdc__center__short_name	UNC
gdc__created_datetime	2016-05-26T21:19:35.542302-05:00,2016-05-26T21:19:35.271686-05:00,2016-05-26T21:19:35.744010-05:00
gdc__data_category	Transcriptome Profiling
gdc__data_format	TXT
gdc__data_type	Gene Expression Quantification
gdc__demographic__age_at_index	61
gdc__demographic__days_to_birth	-22370
gdc__demographic__days_to_death	2405
gdc__demographic__demographic_id	e04e3f25-8f2c-5c45-9d50-1819a0cc3c0a
gdc__demographic__ethnicity	not reported
gdc__demographic__gender	female
gdc__demographic__race	not reported
gdc__demographic__vital_status	Dead
gdc__demographic__year_of_birth	1947
gdc__diagnoses__age_at_diagnosis	22370
gdc__diagnoses__ajcc_clinical_m	M0
gdc__diagnoses__ajcc_pathologic_n	N0
gdc__diagnoses__ajcc_pathologic_t	T2
gdc__diagnoses__classification_of_tumor	not reported
gdc__diagnoses__days_to_diagnosis	0
gdc__diagnoses__days_to_last_follow_up	2102
gdc__diagnoses__diagnosis_id	bbc899ca-b467-5687-b840-66ce02b6d940
gdc__diagnoses__last_known_disease_status	not reported
gdc__diagnoses__morphology	8370/3
gdc__diagnoses__primary_diagnosis	Adrenal cortical carcinoma
gdc__diagnoses__prior_malignancy	no
gdc__diagnoses__prior_treatment	No
gdc__diagnoses__progression_or_recurrence	not reported
gdc__diagnoses__site_of_resection_or_biopsy	Cortex of adrenal gland
gdc__diagnoses__tissue_or_organ_of_origin	Cortex of adrenal gland
gdc__diagnoses__tumor_grade	not reported
gdc__diagnoses__tumor_stage	stage ii
gdc__diagnoses__year_of_diagnosis	2008
gdc__disease_type	Adenomas and Adenocarcinomas
gdc__experimental_strategy	RNA-Seq
gdc__exposures__alcohol_history	Not Reported
gdc__exposures__exposure_id	08837923-718b-5d12-ae09-8b43d9aae82f
gdc__file_id	98e70b10-be6a-43d9-8c8e-0c7354e4d625,c1d41401-9e14-427a-9b03-83caea8b9669,b13850ad-8815-4901-b306-a8e991c96844
gdc__file_name	e6f0f18e-2e3b-430d-a51a-180daa250e0c.FPKM-UQ.txt.gz,e6f0f18e-2e3b-430d-a51a-180daa250e0c.htseq.counts.gz,e6f0f18e-2e3b-430d-a51a-180daa250e0c.FPKM.txt.gz
gdc__file_size	509533,251698,507700
gdc__input_files__access	controlled
gdc__input_files__data_category	Sequencing Reads
gdc__input_files__data_format	BAM
gdc__input_files__data_type	Aligned Reads
gdc__input_files__experimental_strategy	RNA-Seq
gdc__input_files__file_id	8232cb81-ddd1-4ad4-a6bc-a9fef00c174e
gdc__input_files__file_name	aa230c20-8500-46e2-aa4e-0264af8fbf4a_gdc_realn_rehead.bam
gdc__input_files__file_size	7743715290
gdc__input_files__md5sum	aa2bd0a24ff56179337a2ea743d7fa3f
gdc__input_files__platform	Illumina
gdc__md5sum	e0bc1624720b17839561d09d17061512,6e7c8b56527e519d7164827c24cb9f9b,1e0e1437632641af225ea92f95ff4e2d
gdc__portions__is_ffpe	false
gdc__portions__portion_id	cb765114-b8d9-4d40-af16-8755ef9c24e3
gdc__portions__portion_number	11
gdc__portions__weight	30.0
gdc__primary_site	Adrenal gland
gdc__program__dbgap_accession_number	phs000178
gdc__program__name	TCGA
gdc__program__program_id	b80aa962-9650-5110-b3eb-bd087da808db
gdc__project__disease_type	Adrenocortical Carcinoma
gdc__project__project_id	TCGA-ACC
gdc__project__releasable	false
gdc__project__released	true
gdc__samples__days_to_collection	1700
gdc__samples__initial_weight	170.0
gdc__samples__is_ffpe	false
gdc__samples__oct_embedded	true
gdc__samples__pathology_report_uuid	45C2478C-53EF-4422-A9EF-33C40A3AA275
gdc__samples__sample_id	55ee2b0e-feff-4f93-982a-5b64820b7a34
gdc__samples__sample_type	Primary Tumor
gdc__samples__sample_type_id	01
gdc__samples__tissue_type	Not Reported
gdc__slides__percent_lymphocyte_infiltration	0.0
gdc__slides__percent_monocyte_infiltration	0.0
gdc__slides__percent_necrosis	0.0
gdc__slides__percent_neutrophil_infiltration	0.0
gdc__slides__percent_normal_cells	0.0
gdc__slides__percent_stromal_cells	0.0
gdc__slides__percent_tumor_cells	100.0
gdc__slides__percent_tumor_nuclei	95.0
gdc__slides__section_location	TOP
gdc__slides__slide_id	da350476-530a-405a-b1bb-44eb1ab91bbd
gdc__submitter_id	e6f0f18e-2e3b-430d-a51a-180daa250e0c_uqfpkm,e6f0f18e-2e3b-430d-a51a-180daa250e0c_count,e6f0f18e-2e3b-430d-a51a-180daa250e0c_fpkm
gdc__tissue_source_site__bcr_id	NCH
gdc__tissue_source_site__code	OR
gdc__tissue_source_site__name	University of Michigan
gdc__tissue_source_site__tissue_source_site_id	2ff9cebf-b83f-5ec2-aae4-3aa1bf1bb02d
gdc__treatments__treatment_id	a9e25684-5d55-55fd-8aca-85991689d79e
gdc__treatments__treatment_or_therapy	yes
gdc__treatments__treatment_type	Pharmaceutical Therapy, NOS,Pharmaceutical Therapy, NOS
gdc__type	gene_expression
gdc__updated_datetime	2019-09-18T14:38:42.659845+00:00
manually_curated__data_format	BED
manually_curated__download_date	2019-11-05T21:19:46.946+01:00
manually_curated__exp_data_bed_url	ftp://geco.deib.polimi.it/opengdc/bed/tcga/tcga-acc/gene_expression_quantification/a70e4d3e-993e-4ab7-95b9-1c52f452ef63-geq.bed
manually_curated__exp_metadata_url	ftp://geco.deib.polimi.it/opengdc/bed/tcga/tcga-acc/gene_expression_quantification/a70e4d3e-993e-4ab7-95b9-1c52f452ef63-geq.bed.meta
manually_curated__genome_built	GRCh38
manually_curated__local_file_size	5102285
manually_curated__local_md5	98ecfc4dc39e49a436fa98da70505aee
manually_curated__opengdc_download_date	2019-09-12T10:50:17.000000+02:00
manually_curated__opengdc_file_md5	b2642dd8b192f5d13da015bce9d19f70
manually_curated__opengdc_file_size	5102284
manually_curated__opengdc_id	a70e4d3e-993e-4ab7-95b9-1c52f452ef63-geq
manually_curated__origin_file_size	5102284
manually_curated__origin_last_modified_date	Mon Sep 30 16:53:00 CEST 2019
manually_curated__origin_md5	b2642dd8b192f5d13da015bce9d19f70
manually_curated__tissue_status	tumoral
